Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug ...

Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

The U.S. government and academic labs are pushing multiple universal vaccine candidates through early clinical trials, targeting influenza strains and coronaviruses that mutate faster than today’s ...

Need a quote from a Motley Fool analyst? In conjunction with today's call, we have provided a presentation that will be referenced during our remarks that is posted to the Investor Relations section ...

Advancing AX-0810 through ongoing Phase 1 dosing, with target engagement data expected 1H 2026Selected Development Candidates AX-2402 for Rett ...

Co-founders, Prof Ugur Sahin and Prof Özlem Türeci, will depart to establish a new, independent biotechnology company.

Over the past decade, the economics of drug development have become increasingly unforgiving. Global pharmaceutical R&D spending now exceeds $300 billion annually, yet bringing a new therapy to market ...

A new chapter is unfolding for gene therapies in Europe. With retinal programs advancing into Phase I/II trials and regulators introducing more flexible approval pathways for rare diseases, the field ...

Record Quarterly and Annual Revenues, Up 48.4% and 11.7% Year-Over-Year, Respectively First GAAP Profitable Quarter; Adjusted Net Income 1 ...

Following the appointment of a new leadership team on March 9, 2026, Tevogen is accelerating its "Biotech" and "Digital Health" verticals to move TVGN 489 into its next clinical phase. The company is ...

Activision has revealed the patch notes for Call of Duty Warzone and Black Ops 7 Season 2 Reloaded update 1.95/1.095.